IBDEI1S2 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29759,2)
 ;;=^5003618
 ;;^UTILITY(U,$J,358.3,29760,0)
 ;;=F52.22^^135^1368^93
 ;;^UTILITY(U,$J,358.3,29760,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29760,1,3,0)
 ;;=3^Sexual Arousal Disorder,Female
 ;;^UTILITY(U,$J,358.3,29760,1,4,0)
 ;;=4^F52.22
 ;;^UTILITY(U,$J,358.3,29760,2)
 ;;=^5003621
 ;;^UTILITY(U,$J,358.3,29761,0)
 ;;=F52.8^^135^1368^94
 ;;^UTILITY(U,$J,358.3,29761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29761,1,3,0)
 ;;=3^Sexual Dysfnct Not d/t Substance/Known Physiological Cond
 ;;^UTILITY(U,$J,358.3,29761,1,4,0)
 ;;=4^F52.8
 ;;^UTILITY(U,$J,358.3,29761,2)
 ;;=^5003624
 ;;^UTILITY(U,$J,358.3,29762,0)
 ;;=F52.21^^135^1368^33
 ;;^UTILITY(U,$J,358.3,29762,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29762,1,3,0)
 ;;=3^Erectile Disorder,Male (Psychogenic)
 ;;^UTILITY(U,$J,358.3,29762,1,4,0)
 ;;=4^F52.21
 ;;^UTILITY(U,$J,358.3,29762,2)
 ;;=^5003620
 ;;^UTILITY(U,$J,358.3,29763,0)
 ;;=I12.9^^135^1368^55
 ;;^UTILITY(U,$J,358.3,29763,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29763,1,3,0)
 ;;=3^Hypertensive Kidney Disease Chronic w/ Stg 1-4
 ;;^UTILITY(U,$J,358.3,29763,1,4,0)
 ;;=4^I12.9
 ;;^UTILITY(U,$J,358.3,29763,2)
 ;;=^5007066
 ;;^UTILITY(U,$J,358.3,29764,0)
 ;;=N04.9^^135^1368^69
 ;;^UTILITY(U,$J,358.3,29764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29764,1,3,0)
 ;;=3^Nephrotic Syndrome w/ Unspec Morphologic Changes
 ;;^UTILITY(U,$J,358.3,29764,1,4,0)
 ;;=4^N04.9
 ;;^UTILITY(U,$J,358.3,29764,2)
 ;;=^5015540
 ;;^UTILITY(U,$J,358.3,29765,0)
 ;;=N02.9^^135^1368^50
 ;;^UTILITY(U,$J,358.3,29765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29765,1,3,0)
 ;;=3^Hematuria w/ Unspec Morphologic Changes,Recurrent & Persistent
 ;;^UTILITY(U,$J,358.3,29765,1,4,0)
 ;;=4^N02.9
 ;;^UTILITY(U,$J,358.3,29765,2)
 ;;=^5015520
 ;;^UTILITY(U,$J,358.3,29766,0)
 ;;=N06.9^^135^1368^86
 ;;^UTILITY(U,$J,358.3,29766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29766,1,3,0)
 ;;=3^Proteinuria Isolated w/ Unspec Morphologic Lesion
 ;;^UTILITY(U,$J,358.3,29766,1,4,0)
 ;;=4^N06.9
 ;;^UTILITY(U,$J,358.3,29766,2)
 ;;=^5015558
 ;;^UTILITY(U,$J,358.3,29767,0)
 ;;=N05.9^^135^1368^66
 ;;^UTILITY(U,$J,358.3,29767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29767,1,3,0)
 ;;=3^Nephritic Syndrome w/ Unspec Morphologic Changes
 ;;^UTILITY(U,$J,358.3,29767,1,4,0)
 ;;=4^N05.9
 ;;^UTILITY(U,$J,358.3,29767,2)
 ;;=^5134086
 ;;^UTILITY(U,$J,358.3,29768,0)
 ;;=N07.9^^135^1368^68
 ;;^UTILITY(U,$J,358.3,29768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29768,1,3,0)
 ;;=3^Nephropathy Hereditary w/ Unspec Morphologic Lesions
 ;;^UTILITY(U,$J,358.3,29768,1,4,0)
 ;;=4^N07.9
 ;;^UTILITY(U,$J,358.3,29768,2)
 ;;=^5015568
 ;;^UTILITY(U,$J,358.3,29769,0)
 ;;=N15.9^^135^1368^92
 ;;^UTILITY(U,$J,358.3,29769,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29769,1,3,0)
 ;;=3^Renal Tubulo-Interstitial Disease,Unspec
 ;;^UTILITY(U,$J,358.3,29769,1,4,0)
 ;;=4^N15.9
 ;;^UTILITY(U,$J,358.3,29769,2)
 ;;=^5015596
 ;;^UTILITY(U,$J,358.3,29770,0)
 ;;=N17.9^^135^1368^61
 ;;^UTILITY(U,$J,358.3,29770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29770,1,3,0)
 ;;=3^Kidney Failure,Acute,Unspec
 ;;^UTILITY(U,$J,358.3,29770,1,4,0)
 ;;=4^N17.9
 ;;^UTILITY(U,$J,358.3,29770,2)
 ;;=^338532
 ;;^UTILITY(U,$J,358.3,29771,0)
 ;;=N19.^^135^1368^62
 ;;^UTILITY(U,$J,358.3,29771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29771,1,3,0)
 ;;=3^Kidney Failure,Unspec
 ;;^UTILITY(U,$J,358.3,29771,1,4,0)
 ;;=4^N19.
 ;;^UTILITY(U,$J,358.3,29771,2)
 ;;=^5015607
 ;;^UTILITY(U,$J,358.3,29772,0)
 ;;=N11.0^^135^1368^90
 ;;^UTILITY(U,$J,358.3,29772,1,0)
 ;;=^358.31IA^4^2
